"ملف 8/4 I محظورات: استيراد الأفيون إلى البحرين" [ظ‎‎٢‎٠‎٨] (٤٦١/٤١٥)

CRUDE COCAINE
(To be given in terms of crude cocaine.)
GL II.
Quantity received in factories
Quantity of pure cocaine which is contained in this crude cocaine or which is producible
therefrom kg.
Quantity manufactured*, including the quantities used for the manufacture of (or for
conversion into) the substances referred to under GL IV
(1 he quantities in process of manufacture at the end of the year should not be included here,
but under the same item (GL II) in Form C (2) (GL) to be submitted for the year during which
the process of manufacture is completed.)
L III. Quantity disposed of by manufacturers, not including the quantities used in the manufacture
of (or for conversion into) the substances referred to under GL IV
GL IV, Quantity used in the manufacture of**:
(a) Cocaine
or for conversion into**:
[h) Other drugs mentioned in Article 1 of the Limitation Convention and those coming
under the provisions of the Geneva Convention in accordance with Article to
(To be given separately.)
Kg-
\l
(c) Substances not covered by the Conventions
(To be given separately.)
When crude cocaine has been manufactured and put into stock or passes into commerce, the figures should be entered undei
GL II, but not when it has been obtained in the course of a continuous process for the manufacture of pure cocaine.
** هذه التواريخ تقريبية Including the quantities in process of such manufacture or of conversion at the end of the year.
ECGONINE AND THE ESTERS OF ECGONINE
This heading refers to ecgonine and its salts, and the esters of ecgonine and their salts.
(In the case of the salts, only the weight of the pure alkaloid content should be given.)
Esters of ecgonine
and their salts
Name of
ester*
L I. Quantity received in factories
GL II. Quantity manufactured**; including the quantities used for conversion into
the substances referred to under GL IV
(The quantities in process of manufacture at the end of the year should not
be included here, but under the same item (GL II) in Form C (2) (GL) to be
submitted for the year during which the process of manufacture is completed.)
L III. Quantity disposed of by manufacturers, not including the quantities used
for conversion into the substances referred to under GL IV
GL IV. Quantity used for conversion into***:
{a) Cocaine
(6) Other drugs mentioned in Article 1 of the Limitation Convention
and those coming under the Geneva Convention in accordance
with Article 10
(To be given separately.)
(c) Substances not covered by the Conventions
(To be given separately.)
♦ Separate figures should be given in respect of each ester of ecgonine, further columns being added, if necessary.
♦♦ When ecgonine manufactured is put into stock or passes into commerce, the figures should be entered under GL II, but not when it has
been produced as part of a continuous process for the manufacture of pure cocaine.
Including the quantities in process of conversion at the end of the year.